ISO 13485 Certified Dental Device Programs FDA Reg. support · CE MDR files · UDI-ready catalog · FSE service desk
Clinical insight

Hemodialysis Machines Sourcing: Four Buyer Scenarios and the TCO Math Behind Each

2026-11-20 · Samuel Okafor

When someone asks me what a hemodialysis machine costs, I usually answer with a question: what are you actually buying? A machine, a treatment station, or an entire water-and-waste system? The number changes depending on which one you mean.

Here's the thing—there's no universal "best" way to source dialysis equipment. I've been in procurement for about six years, most of it spent on medical equipment categories, and I've negotiated with 30+ vendors. The right approach depends almost entirely on which buying scenario you're in.

Four common ones:

  1. Building a new dialysis unit from zero
  2. Expanding or replacing equipment at an existing site
  3. Setting up home or portable dialysis
  4. Reselling or refurbishing

Same product category. Very different cost math. Let me walk through each one, then give you four questions to figure out which one is yours.

Scenario 1: Building a New Dialysis Unit from Scratch

If you're starting from an empty room, the machine is the easy part. The expensive part is everything around it.

Most first-time buyers focus on the per-machine quote and completely miss the water treatment and installation scope. That's where the budget quietly falls apart. Reverse osmosis systems, plumbing retrofits, electrical upgrades, commissioning, staff training, and the first service contract can add up fast.

I learned this in 2023 when I compared two quotes for a small unit build. One looked cleaner on paper. Then I itemized the RO loop, the electrical work, the biomedical training, and a year of service. The quote that looked cheaper upfront wasn't cheaper anymore. I'm not 100% sure the gap would hold in every market, but the pattern has repeated often enough that I now ask for itemized quotes by default.

So glad I insisted on the breakdown. Almost signed an "all-inclusive" package that excluded the RO loop and left us scrambling.

What to ask: does the quote include delivery, uncrating, installation, calibration, and staff training? Who pays for the first service visit? What's excluded? A turnkey quote can be fine—but only if you know what "turnkey" actually covers.

One more thing. For any patient-facing equipment, verify the regulatory status in your jurisdiction before you commit. I'm not a regulatory specialist, so I won't pretend to advise on that—but I always loop in someone who is.

Scenario 2: Expanding or Replacing Equipment at an Existing Site

This one looks simpler than it is. You already have machines, staff, and probably a service contract. The temptation is to buy the same model again and move on.

Do the boring paperwork first. Pull your existing service contract and check whether adding machines changes the coverage or the rate. Some contracts treat a mixed fleet as a new risk tier. Others don't care. You won't know until you read the fine print.

Then check consumable compatibility. If your current setup is locked into a specific manufacturer's consumables, a "cheaper" machine from another brand might cost more per treatment over three years. This is the part people skip.

The "never mix brands" thinking comes from an era when service contracts punished you for it. That's changed—somewhat. Today, third-party service is more available, and independent biomedical teams can handle more than they used to. But it's still not a free-for-all. Verify before you assume.

Refurbished units can make sense here, especially for backup or overflow capacity. But I'd keep them on a short leash: confirm warranty transfer, confirm service history, and confirm that spare parts are actually available. A refurb with no documentation is a project, not a purchase.

I've seen this pattern many times. But when I say "many," I do not mean every case—I mean enough times that our procurement policy now requires a service-contract review before any fleet addition gets approved.

Scenario 3: Setting Up Home or Portable Dialysis

Here's the counterintuitive part: the machine is probably not the main cost.

Home dialysis sourcing is a support-logistics business dressed up as a hardware purchase. Training, remote monitoring, home visits, backup power and water planning, patient troubleshooting, and replacement-unit logistics often outweigh the sticker price over a three-to-five-year horizon. If you budget only for hardware, you'll be back asking for more money within a year.

The question everyone asks is "which home machine is best?" The question they should ask is "who handles a 2 a.m. alarm?" That second question tells you more about your real cost structure than any spec sheet.

I don't have hard data on industry-wide home unit failure rates, but based on our service tickets, my sense is that support logistics cause more headaches than hardware faults. Take that with a grain of salt—it's anecdotal.

Also, don't treat peritoneal systems as a footnote. They're a different modality with different infrastructure needs. I'm not going to tell you one is better than the other, because that depends on the patient and the program. But from a sourcing standpoint, you should at least price out both paths before committing to a fleet.

The support layer is sorta the whole budget in disguise. Plan for it explicitly.

Scenario 4: Reselling or Refurbishing

If you're not the end user, your risk profile is different. You're buying documentation as much as hardware.

Three things matter more than price: warranty chain, spare parts availability, and regulatory status in the destination market. Most markets publish device registration databases—use them. A unit that's perfectly legal in one country might be a paperwork problem in another.

The "refurb is always a gamble" belief comes from an era when the market was dominated by informal resellers with no service records. Today, organized refurbishers do exist, and some run proper QA processes. But the variance is still huge. Ask for service history, verify serial numbers, and get the warranty terms in writing. If a seller can't produce documentation, treat that as a data point.

Cheap units with no paperwork aren't cheap. They're expensive to place, expensive to insure, and expensive to explain when something goes wrong.

How to Tell Which Scenario You're In

Four questions. Answer them honestly.

1. Are you building from zero or adding to an existing fleet?
Zero means Scenario 1. Adding means Scenario 2—and it means reading your service contract before anything else.

2. Who operates the machine—staff or patient?
If a patient or caregiver runs it at home, you're in Scenario 3. That's a support business, not a hardware business.

3. Will you service it in-house or rely on a vendor?
If you're vendor-dependent, the service contract is part of the purchase. Price it that way.

4. Is the end user in your market, or are you moving units across borders?
Cross-border means Scenario 4. Documentation and registration status move to the top of the checklist.

If you're straddling two scenarios—say, expanding a fleet while also setting up a home program—run the TCO math separately for each. Mixing them is how good budgets go bad.

The Only Rule That Applies to All Four

The lowest quoted price is rarely the lowest total cost. Add the line items people forget: installation, training, service, consumables, downtime, and the cost of finding out later that something was excluded.

I keep a simple TCO sheet for every dialysis equipment purchase now. It has 11 rows. The first row is the quote. The other 10 are where the real decisions live.

Samuel Okafor

Samuel Okafor

Samuel Okafor is an in-vitro diagnostics and clinical laboratory equipment analyst covering chemistry and hematology analyzers, immunoassay systems, PCR platforms, centrifuges, and electronic pipettes. He applies IEC 61010-2-101 and examines analytical sensitivity, precision, carryover, calibration traceability, sample throughput, reagent stability, reportable range, and operator maintenance requirements. His guides help laboratory directors, clinical scientists, quality teams, and buyers evaluate assay performance, biosafety, automation capacity, consumable dependence, and total workflow cost.